Medical News

RSS

Florida Hospital Zephyrhills achieves Heart Failure Institute accreditation

The Healthcare Accreditation Colloquium announced today that the Heart Institute at Florida Hospital Zephyrhills has achieved status as the state's first accredited Heart Failure Institute.

28 Jun 2010

TRL commences operations at San Diego facility with focus on biological drugs for autoimmune diseases

Tanabe Research Labs USA, Inc. (TRL) today announced commencement of its new operations at the TRL facility in San Diego with a focus on biological drugs for the treatment of autoimmune diseases. TRL began its new activities in May with the appointment of three new senior executives: Masaki Yamada, Ph.D., Chief Executive Officer; Toshihiro Hosaka, Ph.D., Senior Vice President, and Roland Newman, Ph.D., VP and Chief Scientific Officer.

28 Jun 2010

Elevated blood levels of HDL can be harmful to women with type 1 diabetes: Study

Elevated blood levels of high-density lipoprotein or "good" cholesterol, typically thought to protect against heart disease, may do the opposite in women with type 1 diabetes, according to a University of Pittsburgh Graduate School of Public Health study being presented at the 70th Scientific Sessions of the American Diabetes Association.

28 Jun 2010

Medtronic introduces new Midas Rex Legend EHS Stylus Touch drill for spinal, cranial, orthopaedic procedures

Medtronic, Inc. today announced availability of the company's new Midas Rex® Legend® EHS Stylus Touch™ high-speed electric drill for spinal, cranial and orthopaedic surgical procedures. This is the first electric drill from Medtronic with integrated finger control and is based on the well-established Legend EHS Stylus® motor.

28 Jun 2010

Poster presentation at MASCC Conference summarizes MuGard clinical experience

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, is presenting a scientific poster today at the Multinational Association of Supportive Care in Cancer Conference in Vancouver, B.C. The poster presentation, co-authored by Dr. David Nowotnik of Access Pharmaceuticals and Dr. Caroline Dumas of SpePharm Holdings, summarizes MuGard clinical experience from cancer patients globally undergoing radiotherapy and/or chemotherapy.

28 Jun 2010

FDA grants orphan drug designation for Chiasma's Octreolin

Chiasma, Inc., a privately held biopharma company, announced that the Food and Drug Administration has granted orphan drug designation for Chiasma's investigational new drug, Octreolin, an oral form of octreotide acetate that uses the Company's proprietary Transient Permeability Enhancer technology for the oral treatment of acromegaly, a hormonal disorder that results from an excess of growth hormone.

28 Jun 2010

Phase 2 proof-of-concept data for Novo Nordisk's degludec presented at ADA 2010

Novo Nordisk today presented phase 2 proof-of-concept data for its investigational insulin degludec, an ultra-long-acting basal insulin, which demonstrated the potential to help achieve target glycemic control when used once daily or three times weekly. These data were presented at the 70th Scientific Sessions of the American Diabetes Association.

28 Jun 2010

OPQC Scheduled Birth Initiative reduces unnecessary planned late pre-term, near-term deliveries in Ohio

A statewide Ohio program significantly reduced the monthly rate of inappropriately scheduled births before 39 weeks gestation, helping to avoid expensive neonatal intensive care unit admissions and decrease the risk of infant deaths, according to two studies by the Ohio Perinatal Quality Collaborative recently published in the American Journal of Obstetrics & Gynecology.

28 Jun 2010

EDF praises New York State Assembly for passing legislation to reduce sulfur levels in heating oil

Environmental Defense Fund praised the New York State Assembly for passing legislation today to dramatically reduce sulfur levels in the commonly used #2 heating oil sold in the state. The State Senate passed the legislation last week and Governor Paterson is expected to sign it into law.

28 Jun 2010

Mass. bill would lift gift ban; Workers rally in Md., Minn.

"A two-year-old state ban on gifts in the medical and pharmaceutical industries would be repealed under an economic development bill that the House budget committee began polling its members on yesterday. The ban, which prohibits drug firms from giving gifts and meals to health care professionals, has cut back on local business profits, a summary of the bill states. When it passed as part of a broader health care bill in 2008, supporters called it a way of curbing pharmaceutical companies' influence" (O'Sullivan, 6/25).

28 Jun 2010

New affiliation formed to accelerate nation's progress in fighting HIV/AIDS

Two leading institutions in public health and health policy are joining forces to accelerate the nation's progress in fighting HIV/AIDS, hepatitis C and tuberculosis in Washington – the Forum for Collaborative HIV Research and the University of California, Berkeley, School of Public Health.

28 Jun 2010

JANUMET results in greater blood sugar reductions in patients with type 2 diabetes compared to pioglitazone

New data were presented at the American Diabetes Association 70th Annual Scientific Sessions from a study comparing JANUMET (sitagliptin/metformin) to pioglitazone. In this study, JANUMET resulted in significantly greater blood sugar reductions in patients with type 2 diabetes compared with pioglitazone.

28 Jun 2010

Lantus and Apidra injections improve glycemic control, reduce hospital complications: Study

Sanofi-aventis announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT-2 Surgery) found that treatment with a basal-bolus regimen that included Lantus (insulin glargine [rDNA origin] injection) once-daily and Apidra (insulin glulisine [rDNA origin] injection) before meals improved glycemic control and reduced hospital complications, compared to "sliding scale" insulin in general surgery patients with type 2 diabetes.

28 Jun 2010

World Vision calls upon emerging economies within G20 to prioritize child and maternal health progress

With the G20 summit opening today in Toronto, World Vision is calling upon emerging economies within the G20 to be accountable for prioritizing their own child and maternal health progress -- and for all G20 nations to provide their fair share of funding and leadership within their respective regions.

28 Jun 2010

EpiCept signs definitive agreements for purchase of 6.1M shares of common stock

EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.

28 Jun 2010

Scientists uncover variations in X chromosome inactivation in early passages of female embryonic stem cells

Human embryonic stem cells hold great promise for studying and treating disease and for the practice of regenerative medicine. However, more must be learned to ensure the cells that may one day be transplanted into humans are safe.

28 Jun 2010

New center opens for vets with traumatic brain injuries and psychological issues

"The $65 million medical center, which opened Thursday, is devoted exclusively to helping members of the military who suffer from traumatic brain injuries, PTSD and other psychological issues. Its opening comes on the heels of a flurry of congressional criticism and reports claiming that soldiers with traumatic brain injuries often do not have their conditions diagnosed and are forced to wade through the vast bureaucracy of the Defense Centers of Excellence for Psychological Help and Traumatic Brain Injury, which is charged with their treatment."

28 Jun 2010

Hospital for Special Surgery announces receipt of $5M commitment from CA Technologies

Hospital for Special Surgery announced the receipt of a $5 million commitment from CA Technologies, an IT management software and solutions company, at its 27th Annual Tribute Dinner at the Waldorf Astoria on June 21, 2010.

28 Jun 2010

Phase III clinical trials: Linagliptin achieves significant, sustained reductions in blood sugar

Data from four pivotal Phase III clinical trials demonstrate that linagliptin achieved statistically significant and sustained reductions in blood sugar as measured by hemoglobin A1c, fasting plasma glucose and postprandial glucose. Boehringer Ingelheim Pharmaceuticals, Inc. is investigating the dipeptidyl peptidase 4 inhibitor as an oral once-daily tablet, as monotherapy and combination therapy, to treat type 2 diabetes.

28 Jun 2010

G8 leaders to discuss economic policy, developing world, maternal and child health, Haitian rebuilding

Ahead of the G8 summit, which begins Friday in Canada, "leaders engaged in a series of dueling letters and interviews that exposed their conflicts" in how to foster global economic recovery, the Associated Press reports.

28 Jun 2010

Medical News

Florida Hospital Zephyrhills achieves Heart Failure Institute accreditation

TRL commences operations at San Diego facility with focus on biological drugs for autoimmune diseases

Elevated blood levels of HDL can be harmful to women with type 1 diabetes: Study

Medtronic introduces new Midas Rex Legend EHS Stylus Touch drill for spinal, cranial, orthopaedic procedures

Poster presentation at MASCC Conference summarizes MuGard clinical experience

FDA grants orphan drug designation for Chiasma's Octreolin

Phase 2 proof-of-concept data for Novo Nordisk's degludec presented at ADA 2010

OPQC Scheduled Birth Initiative reduces unnecessary planned late pre-term, near-term deliveries in Ohio

EDF praises New York State Assembly for passing legislation to reduce sulfur levels in heating oil

Mass. bill would lift gift ban; Workers rally in Md., Minn.

New affiliation formed to accelerate nation's progress in fighting HIV/AIDS

JANUMET results in greater blood sugar reductions in patients with type 2 diabetes compared to pioglitazone

Lantus and Apidra injections improve glycemic control, reduce hospital complications: Study

World Vision calls upon emerging economies within G20 to prioritize child and maternal health progress

EpiCept signs definitive agreements for purchase of 6.1M shares of common stock

Scientists uncover variations in X chromosome inactivation in early passages of female embryonic stem cells

New center opens for vets with traumatic brain injuries and psychological issues

Hospital for Special Surgery announces receipt of $5M commitment from CA Technologies

Phase III clinical trials: Linagliptin achieves significant, sustained reductions in blood sugar

G8 leaders to discuss economic policy, developing world, maternal and child health, Haitian rebuilding

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News